X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

DRUG METABOLISM REVIEWS

期刊標題檢索 DRUG METAB REV 最新評論: 11.1 Submission 11.14 Editor review 11.28 External review 12.6... (2024-03-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[DRUG METABOLISM REVIEWS]您好,您是該頁面的第 18766 位訪客。

期刊簡介
期刊名稱DRUG METABOLISM REVIEWS DRUG METABOLISM REVIEWS
LetPub Score
7.6
50 ratings
Rate

Reputation
8.7

Influence
6.2

Speed
9.3

期刊簡稱DRUG METAB REV
ISSN0360-2532
E-ISSN1097-9883
h-index89
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.100.8701.170
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q13 / 80
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology (medical)
Q113 / 272

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.
官方網站http://informahealthcare.com/dmr
在線稿件提交https://mc.manuscriptcentral.com/ldmr
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年1972
每年文章數20每年文章數趨勢
黃金OA百分比14.93%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ2105/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0360-2532%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Invited contributions ? Irregular
競爭力 *來自作者的數據: Ordinary
參考鏈接
相關期刊 【DRUG METABOLISM REVIEWS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498328
    PHYTOMEDICINE340267
    LIFE SCIENCES285760
    International Journal of Pharmaceutics242440
    PHARMACOLOGICAL RESEARCH241279
    European Journal of Pharmacology204248
    BIOCHEMICAL PHARMACOLOGY202691
    JOURNAL OF NATURAL PRODUCTS196695
    BRITISH JOURNAL OF PHARMACOLOGY165139
    MOLECULAR PHARMACEUTICS162832
  •  

    DRUG METABOLISM REVIEWS DRUG METABOLISM REVIEWS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [DRUG METABOLISM REVIEWS] 的評論撰寫評論
作者: yee4731


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-03-01 09:49:57 評論於
11.1 Submission 
11.14 Editor review 
11.28 External review 
12.6 Update on external review 
1.5 Minor revisions requested 
1.10 Acceptance after revisions 
1.16 Online 
1.18 Proofreading 
1.30 Published

Overall, the process was quite balanced and the feedback for revisions was detailed, correcting grammar and word errors. The reviewer seems to be an expert in metabolism, providing additional information on pharmacokinetics. The acceptance after revisions was prompt on the same day. As long as the quality of the article is ensured, it shouldn't be too difficult
(0) 讚! | yee4731

作者: cecilia-y


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-09-17 23:35:10 評論於
After being rejected twice after submission, they are still welcome to submit again.
After the third submission, they were directly hired without being reviewed again.
It's quite mysterious.
I hope the child can work harder to improve and rise again.
(0) 讚! | cecilia-y

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 17:53:35 評論於
Stuck at this juncture, it's not easy to push forward anymore. At over 4 points, it's considered satisfactory
(0) 讚! | 凌霄高洁

作者: 409296492@qq.com


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2016-09-17 22:56:33 評論於
This is a traditional journal in the field. Our manuscript went through two rounds of revisions. Both rounds took one month to receive the reviews and then a few weeks or so to complete the revisions. The reviewers’ comments were harsh but pertinent… submitting to journals with reputations like this one aren’t easy.

(0) 讚! | 409296492@qq.com

作者: 五郎梓奥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-09-17 20:49:11 評論於
One month for the first review, with comments for major revisions from two reviewers, then one week for revisions and comments for minor revisions from two other reviewers. Accepted after one month, and published one week later in a prestigious journal. It's not easy
(0) 讚! | 五郎梓奥

作者: 匿名


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-09-03 20:38:00 評論於
Journal Homepage URL: http://informahealthcare.com/dmr
(0) 讚! | 匿名

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-01-14 20:06:32 評論於
I think as long as the quality of the article meets the standard and is useful for future researchers, it can be accepted. There are already 2 articles published in this journal, both with minor revisions
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [DRUG METABOLISM REVIEWS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*